D'Angelo, Barbara <br/><br/>
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.  [electronic resource] 

 -  Neuropharmacology  Feb 2016 
 - 13-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2015.09.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Brain--drug effects<br/>Brain Infarction--etiology<br/>Caspase 3--metabolism<br/>Cerebrovascular Circulation--drug effects<br/>Disease Models, Animal<br/>Doublecortin Domain Proteins<br/>Drug Administration Schedule<br/>Enzyme Inhibitors--therapeutic use<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Glycogen Synthase Kinase 3 beta<br/>Hippocampus--pathology<br/>Hypoxia-Ischemia, Brain--drug therapy<br/>Indoles--therapeutic use<br/>Maleimides--therapeutic use<br/>Mice<br/>Mice, Inbred C57BL<br/>Microtubule-Associated Proteins--metabolism<br/>Nerve Tissue Proteins--metabolism<br/>Neuropeptides--metabolism<br/>STAT3 Transcription Factor--genetics<br/>Stem Cells--drug effects<br/>Subcellular Fractions--drug effects